Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data

被引:8
|
作者
Reynolds, Shannon [1 ]
Kaufman, Harvey [2 ]
Meyer III, William [2 ]
Bush, Chris [1 ]
Cohen, Oren [3 ]
Cronin, Kathy [4 ]
Kabelac, Carly [1 ]
Leonard, Sandy [5 ]
Anderson, Steve [3 ]
Petkov, Valentina [4 ]
Lowy, Douglas [4 ]
Sharpless, Norman [4 ]
Penberthy, Lynne [4 ]
机构
[1] Aetion Inc, Sci & Delivery, New York, NY 10001 USA
[2] Quest Diagnost, Med Affairs, Secaucus, NJ USA
[3] Labcorp Drug Dev, Off Chief Med Off, Burlington, NC USA
[4] NCI, Div Canc Control & Populat Sci, Bethesda, MD USA
[5] HealthVer, Parternships & Real World Data, Philadelphia, PA USA
来源
PLOS ONE | 2023年 / 18卷 / 03期
关键词
INFECTION; ANTIBODIES;
D O I
10.1371/journal.pone.0280584
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This retrospective observational study aimed to gain a better understanding of the protective duration of prior SARS-CoV-2 infection against reinfection. The objectives were two-fold: to assess the durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection, and to evaluate the crude SARS-CoV-2 reinfection rate and associated risk factors. During the pandemic era time period from February 29, 2020, through April 30, 2021, 144,678,382 individuals with SARS-CoV-2 molecular diagnostic or antibody test results were studied. Rates of reinfection among index-positive individuals were compared to rates of infection among index-negative individuals. Factors associated with reinfection were evaluated using multivariable logistic regression. For both objectives, the outcome was a subsequent positive molecular diagnostic test result. Consistent with prior findings, the risk of reinfection among index-positive individuals was 87% lower than the risk of infection among index-negative individuals. The duration of protection against reinfection was stable over the median 5 months and up to 1-year follow-up interval. Factors associated with an increased reinfection risk included older age, comorbid immunologic conditions, and living in congregate care settings; healthcare workers had a decreased reinfection risk. This large US population-based study suggests that infection induced immunity is durable for variants circulating pre-Delta predominance.
引用
收藏
页数:17
相关论文
共 50 条
  • [11] SARS-CoV-2 Antibodies reduce the Risk of Reinfection
    Krome, Susanne
    PNEUMOLOGIE, 2021, 75 (11): : 836 - 836
  • [12] SARS-CoV-2 Antibodies reduce the Risk of Reinfection
    Krome, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (16) : 1032 - 1032
  • [13] Infectivity of SARS-CoV-2 and protection against reinfection in rats
    Yu, Dandan
    Long, Yanghaopeng
    Xu, Ling
    Han, Jian-Bao
    Xi, Jiawei
    Xu, Jianlin
    Yang, Lu-Xiu
    Feng, Xiao-Li
    Zou, Qing-Cui
    Qu, Wang
    Lin, Jiangwei
    Li, Ming-Hua
    Yao, Yong-Gang
    ZOOLOGICAL RESEARCH, 2022, 43 (06) : 945 - 948
  • [14] Infectivity of SARS-CoV-2 and protection against reinfection in rats
    Dandan Yu
    Yanghaopeng Long
    Ling Xu
    Jian-Bao Han
    Jiawei Xi
    Jianlin Xu
    Lu-Xiu Yang
    Xiao-Li Feng
    Qing-Cui Zou
    Wang Qu
    Jiangwei Lin
    Ming-Hua Li
    Yong-Gang Yao
    Zoological Research, 2022, 43 (06) : 945 - 948
  • [15] Real-world experience of arbidol for Omicron variant of SARS-CoV-2
    Zhao, Jingya
    Li, Yong
    Chen, Rong
    Xu, Yanping
    Yang, Qingyuan
    Zhang, Haiqing
    Yin, Zhengxin
    Gu, Weiting
    Hu, Jinsong
    Chen, Li
    Li, Jian
    Ning, Guang
    Cheng, Qijian
    Zhou, Min
    Qu, Jieming
    JOURNAL OF THORACIC DISEASE, 2023, 15 (02) : 452 - +
  • [16] Biosensor for rapid detection of SARS-CoV-2 in real-world samples
    Forinova, Michala
    Pilipenco, Alina
    Visova, Ivana
    Kuncak, Jakub
    Lynn, N. Scott
    Yudin, Petr
    Dostalek, Jakub
    Honig, Vaclav
    Palus, Martin
    Maskova, Hana
    Dycka, Filip
    Sterba, Jan
    Vrabcova, Marketa
    Arnostova, Judita
    Spasovova, Monika
    Tung, Chao-Ping
    Yang, An-Suei
    Dejneka, Alexandr
    Vaisocherova-Lisalova, Hana
    2021 IEEE SENSORS, 2021,
  • [17] SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
    Kubale, John
    Gleason, Charles
    Carreno, Juan Manuel
    Srivastava, Komal
    Singh, Gagandeep
    Gordon, Aubree
    Krammer, Florian
    Simon, Viviana
    MBIO, 2022, 13 (05):
  • [18] Reinfection and reactivation of SARS-CoV-2
    Dowran, Razieh
    Damavandi, Amirmasoud Rayati
    Azad, Talat Mokhtari
    FUTURE VIROLOGY, 2022, : 835 - 844
  • [19] A case with SARS-CoV-2 reinfection from India
    Munivenkatappa, Ashok
    Sahay, Rima R.
    Deshpande, Gururaj R.
    Patil, Deepak Y.
    Shete, Anita M.
    Sapkal, Gajanan N.
    Kumar, Ravish
    Narayana, Marappa
    Yadav, Pragya D.
    Shettar, Vijay
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2022, 40 (01) : 166 - 168
  • [20] Risk of SARS-CoV-2 reinfection after natural infection
    Boyton, Rosemary J.
    Altmann, Daniel M.
    LANCET, 2021, 397 (10280): : 1161 - 1163